계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Xanthus Pharmaceuticals
company
About
Xanthus is a biopharmaceutical company.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25M
- Industries
- Biopharma,Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Xanthus Pharmaceuticals Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, acquisition, and commercialization of small-molecule therapeutics for the treatment of cancer and autoimmune disorders.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$55.80M
Xanthus Pharmaceuticals has raised a total of
$55.80M
in funding over 2 rounds. Their latest funding was raised on
Dec 1, 2006 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 1, 2006 | Series B | $25M | 1 | — | — | Detail |
| Dec 12, 2003 | Series B | $30.80M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Xanthus Pharmaceuticals is funded by 1 investors.
CDP Capital Technology Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
CDP Capital Technology Ventures
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
